Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage
Geographical Focus
United States
Industries Focus
- HealthTech
- Biotech
- Medtech
Investment Size:
20,000 to 500,000 USD
Investor Details
Xcellerant Ventures is a Phoenix-based venture capital firm specializing in early- and seed-stage investments within the HealthTech, MedTech, and BioTech sectors. The firm focuses on identifying and supporting transformative healthcare technologies that enhance quality, efficiency, access, and affordability. Xcellerant Ventures emphasizes a 'people first' philosophy, providing capital and strategic guidance to empower entrepreneurs in revolutionizing healthcare.
The firm's investment strategy centers on partnering with dynamic founders who are humble, open to advice, and driven to effect positive change. Xcellerant Ventures seeks companies that have cleared regulatory hurdles, generate revenue, and demonstrate a clear path to rapid growth. The firm has a particular interest in MedTech, BioTech, and HealthTech sectors, areas where its leadership has decades of combined experience.
Xcellerant Ventures has a track record of strategic partnerships and investments aimed at fostering innovation in the healthcare sector. In April 2025, the firm raised $7 million in partnership with AZ Venture Capital Inc. to invest in Arizona-based healthtech startups. Additionally, in May 2023, Xcellerant Ventures welcomed the Flinn Foundation as a limited partner in its Venture Capital Fund I, further strengthening its commitment to advancing Arizona's bioscience and healthcare sectors. These initiatives underscore Xcellerant Ventures' dedication to supporting the growth and success of the bioscience and healthcare sectors in Arizona, resulting in faster commercialization of transformative solutions and greater impact for the benefit of patients.
Xcellerant Ventures' portfolio includes companies such as CRISPR QC, a biotechnology startup developing a platform to analyze the quality of the CRISPR/CAS9 gene editing system, and DeepLook Medical, a healthtech company specializing in visual enhancement technology for advanced medical imaging. These investments reflect the firm's commitment to backing innovative companies that deliver transformative solutions in the healthcare sector.
For more information, visit Xcellerant Ventures' official website at https://www.xcellerantventures.com/.
Investment Requirements:
- Dynamic founders who are humble, open to advice, and driven to effect positive change.
- Companies that have cleared regulatory hurdles, generate revenue, and demonstrate a clear path to rapid growth.
- Focus on MedTech, BioTech, and HealthTech sectors.
Year Founded: Not specified
Portfolio Companies:
- CRISPR QC
- DeepLook Medical
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
Mentioned In
-
$99.00
-
$24.95
-
$24.95
-
$19.95
-
$19.95
-
$49.95
-
$14.95
Claim this Investor
Are you an official representative of Xcellerant Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim